Exo Biologic’s Phase 1/2 Trial is 1st MSC-derived Extracellular Vesicle Trial Approved by EMA - B...

Exo Biologic’s Phase 1/2 Trial is 1st MSC-derived Extracellular Vesicle Trial Approved by EMA  BioInformant

EXO Biologics and ExoXpert Reach Two Critical Milestones that Advance Exosomes - BioPharm Interna...

EXO Biologics and ExoXpert Reach Two Critical Milestones that Advance Exosomes  BioPharm International

EXO Biologics hopes to gain conditional marketing from Phase I/II BPD trial - Clinical Trials Arena

EXO Biologics hopes to gain conditional marketing from Phase I/II BPD trial  Clinical Trials Arena

ExoXpert, a CDMO launched by EXO Biologics to service increasing worldwide demand for exosomes - ...

ExoXpert, a CDMO launched by EXO Biologics to service increasing worldwide demand for exosomes  BioInformant

Belgium-based EXO Biologics raises €16M to harness the therapeutic potential of exosomes - Silico...

Belgium-based EXO Biologics raises €16M to harness the therapeutic potential of exosomes  Silicon Canals